Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
42.47+0.40 (+0.95%)
At close: 04:00PM EDT
42.80 +0.33 (+0.78%)
After hours: 07:26PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
334,641
334,641
280,259
161,855
103,303
Selling General and Administrative
112,624
112,624
87,589
58,243
45,813
Total Operating Expenses
447,265
447,265
367,848
220,098
149,116
Operating Income or Loss
-447,265
-447,265
-367,848
-220,098
-149,116
Interest Expense
10,567
10,567
3,918
0
-
Total Other Income/Expenses Net
-18,372
-18,372
6,878
-5,393
-3,274
Income Before Tax
-432,339
-432,339
-351,351
-225,334
-152,166
Income Tax Expense
503
503
160
0
-24
Income from Continuing Operations
-432,842
-432,842
-351,511
-225,334
-152,142
Net Income
-432,842
-432,842
-351,511
-225,334
-152,142
Net Income available to common shareholders
-432,842
-432,842
-351,511
-225,334
-152,142
Basic EPS
-2.50
-
-2.32
-1.65
-2.01
Diluted EPS
-2.50
-
-2.32
-1.65
-2.01
Basic Average Shares
156,909
-
151,266
136,577
73,643
Diluted Average Shares
156,909
-
151,266
136,577
73,643